• Entinostat (MS-275): Applied Protocols for Cancer Research

  2026-06-19

  Entinostat (MS-275) delivers selective HDAC1/3 inhibition, driving reproducible anti-proliferative and pro-apoptotic effects in cancer models. This guide translates current evidence and advanced workflows into actionable steps, troubleshooting, and comparative insights for bench scientists using Entinostat from APExBIO.

• Flavopiridol (L868275): Pan-CDK Inhibition for Cancer Resear

  2026-06-19

  Flavopiridol (L868275) is a potent, selective pan-CDK inhibitor that empowers cancer researchers to induce robust cell cycle arrest and apoptosis. This guide details experimental strategies, protocol optimizations, and troubleshooting approaches leveraging APExBIO's Flavopiridol for advanced in vitro and in vivo models.

• Structural Mechanisms of FADD-Procaspase-8-cFLIP Assembly in

  2026-06-18

  This study provides the first atomic-resolution structures of human FADD-procaspase-8-cFLIP death-effector domain (DED) complexes, revealing how these multi-protein assemblies orchestrate the balance between cell survival and apoptosis. The findings have broad implications for cancer research, apoptosis pathway modulation, and the rational design of apoptosis-targeting therapeutics.

• Hexetidine (NSC-17764): Biofilm Resistance and Clinical Impa

  2026-06-18

  Explore how Hexetidine (NSC-17764) overcomes biofilm-associated resistance in oral infections and medical device contexts. This article uniquely bridges mechanistic insight with translational assay guidance for advanced antimicrobial research.

• PKH26 Red Fluorescent Cell Linker Kit: Technical Protocol Gu

  2026-06-17

  The PKH26 Red Fluorescent Cell Linker Kit addresses the need for robust and minimally toxic membrane labeling in cell biology research. It is optimized for tracking cell division and tracing cells in vitro and in vivo, but should not be used for intracellular or non-membrane applications.

• Saikosaponins B1/D Suppress Medulloblastoma via Hedgehog Pat

  2026-06-17

  The reference study demonstrates that Saikosaponin B1 and D, derived from Bupleurum chinense, significantly inhibit medulloblastoma tumor growth in mice by targeting the Smoothened receptor and suppressing Hedgehog pathway activation. These findings clarify the mechanistic basis of their antitumor effects and inform new experimental strategies for Hedgehog pathway modulation in oncological research.

• Pyridostatin TFA: Unveiling G-Quadruplexes in Cancer and Neu

  2026-06-16

  Explore the unique role of Pyridostatin TFA in stabilizing G-quadruplex DNA, with insights into both cancer cell growth inhibition and neurodegenerative disease research. Gain advanced, scientifically grounded perspectives on assay design and translational applications.

• Adiponectin and TAK-242 Mitigate PND via TLR4/NF-κB Suppress

  2026-06-16

  This study demonstrates that adiponectin and the TLR4 inhibitor TAK-242 (Resatorvid) ameliorate splenectomy-induced cognitive deficits in aged rats by suppressing neuroinflammation and oxidative stress through the TLR4/MyD88/NF-κB pathway. The findings support TLR4 pathway modulation as a promising therapeutic strategy for perioperative neurocognitive disorder (PND) and highlight mechanistic differences from prior TLR4 inhibition research.

• Trifluoperazine 2HCl: Dopamine D2 Inhibitor in Bench Researc

  2026-06-15

  Trifluoperazine 2HCl is a nanomolar-potency dopamine D2 receptor inhibitor with proven utility in neuropharmacology, immunology, and translational oncology workflows. Its exceptional solubility, well-characterized pharmacology, and APExBIO’s quality assurance make it a cornerstone tool for researchers seeking reliable dopaminergic pathway modulation and advanced cell-based assay performance.

• Tomivosertib Rapidly Suppresses Human DRG Neuron Hyperactivi

  2026-06-15

  The reference study demonstrates that tomivosertib, a selective MNK inhibitor, rapidly and reversibly suppresses spontaneous ectopic activity in human dorsal root ganglion (DRG) neurons from radiculopathy patients. These findings provide the first direct evidence for targeting MNK signaling in modulating neuropathic pain at the level of human sensory neurons, informing future translational pain research.

• Applied Use of SAG: Smoothened Receptor Agonist in Hh Pathwa

  2026-06-14

  Smoothened Agonist (SAG) is a potent and selective tool for activating the Hedgehog pathway with exceptional control in both in vitro and in vivo models. This article translates bench research into actionable workflows, troubleshooting, and comparative insights—revealing how SAG from APExBIO enables cutting-edge stem cell, neuroprotection, and developmental biology studies.

• Applied Pyridostatin TFA Workflows for G-Quadruplex Research

  2026-06-13

  Pyridostatin TFA empowers advanced telomere biology and neurodegeneration research by providing precise, robust G-quadruplex stabilization. Learn how to implement and optimize experimental workflows, troubleshoot common pitfalls, and unlock new frontiers in DNA secondary structure analysis.

• Transmission Dynamics of Carbapenemase Genes in CREC: Insigh

  2026-06-12

  This study systematically characterizes the prevalence, genetics, and transferability of carbapenemase-encoding genes (CEGs) in carbapenem-resistant Enterobacter cloacae (CREC) isolated from eight teaching hospitals in Guangdong, China from 2022–2024. The research reveals dominant plasmid-mediated blaNDM-1 carriage, high rates of multidrug resistance, and efficient horizontal gene transfer, informing resistance surveillance and intervention strategies.

• CUDC-907: Dual PI3K and HDAC Inhibitor Protocol Guidance

  2026-06-12

  CUDC-907 is a dual PI3K and HDAC inhibitor optimized for in vitro studies of cell signaling, cell cycle arrest, and apoptosis in cancer research models. It is not intended for diagnostic or clinical applications and should be applied strictly within validated laboratory workflows utilizing recommended concentrations and storage protocols.

• Saikosaponins Suppress Medulloblastoma via Hedgehog Pathway

  2026-06-11

  This study demonstrates that Saikosaponin B1 and D, two triterpenoids from Bupleurum chinense, significantly inhibit the growth of medulloblastoma allografts by targeting the Hedgehog (Hh) signaling pathway at the level of Smoothened (SMO). The findings advance understanding of SMO-targeted therapy and may inform novel strategies for Hedgehog-driven cancers.

451 records 14/31 page Previous Next First page 上5页 1112131415 下5页 Last page